The Food and Drug Administration and National Institutes of Health held a joint workshop July 7 on reducing animal testing in research, strikingly announcing that “NIH will no longer seek proposals ...

Stem Pharm, a Madison biotech startup, is using lab-created 3D "organoids" to develop a treatment for Alzheimer's disease. In April, the FDA and NIH announced plans to incentivize so-called "new ...

The FDA is moving away from requiring animal models for investigational new drug (IND) applications for new monoclonal antibodies and some other drug candidates. Animal testing will be "reduced, ...

Please provide your email address to receive an email when new articles are posted on . The FDA plans to reduce and potentially replace animal testing for developing monoclonal antibody therapies and ...

Feinberg Professor emerita Eva Redei’s research had two key components: vats of water and “depressed” rats. Redei found that the rodents, genetically engineered in a Kyoto lab to exhibit depressive ...

Researchers at Stanford University have proposed a concept that could transform modern medicine: lab-grown human “bodyoids” created entirely from stem cells and developed without consciousness. These ...

Several stocks in the health care technology space are moving higher after the market close on Thursday after the U.S. Food and Drug Administration (FDA) announced plans to phase out animal testing ...

Megan Molteni reports on discoveries from the frontiers of genomic medicine, neuroscience, and reproductive tech. She joined STAT in 2021 after covering health and science at WIRED. You can reach ...

CN Bio, a leading provider of Organ-on-a-chip (OOC) Systems and solutions that accelerate drug discovery and development workflows, today announced the launch of its PhysioMimix ® DILI assay kit: ...

Forbes contributors publish independent expert analyses and insights. I'm an American writer working in fiction and nonfiction. If a book’s topic were “farms for the production of beagles for some ...